You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/70983
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLopes, Renato D.-
dc.contributor.authorBecker, Richard C.-
dc.contributor.authorGarcia, David-
dc.contributor.authorHylek, Elaine M.-
dc.contributor.authorGranger, Christopher B.-
dc.contributor.authorLourenço, Dayse M.-
dc.contributor.authorNader, Helena B.-
dc.contributor.authorMaffei, Francisco Humberto de Abreu-
dc.contributor.authorCesena, Fernando H.Y.-
dc.contributor.authorNicolau, José C.-
dc.contributor.authorTimmerman, Ari-
dc.contributor.authorRocha, Ana T.-
dc.contributor.authorPaiva, Edison F.-
dc.contributor.authorGuimaraes, Helio P.-
dc.contributor.authorCarvalho, Antonio C.-
dc.contributor.authorD'Amico, Elbio A.-
dc.contributor.authorMoreira-Filho, Carlos A.-
dc.contributor.authorAldrighi, José M.-
dc.contributor.authorLopes, Antonio C.-
dc.date.accessioned2014-05-27T11:23:53Z-
dc.date.accessioned2016-10-25T18:26:59Z-
dc.date.available2014-05-27T11:23:53Z-
dc.date.available2016-10-25T18:26:59Z-
dc.date.issued2009-04-08-
dc.identifierhttp://dx.doi.org/10.1007/s11239-009-0324-4-
dc.identifier.citationJournal of Thrombosis and Thrombolysis, v. 28, n. 1, p. 106-116, 2009.-
dc.identifier.issn0929-5305-
dc.identifier.urihttp://hdl.handle.net/11449/70983-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/70983-
dc.description.abstractThe importance of thrombosis and anticoagulation in clinical practice is rooted firmly in several fundamental constructs that can be applied both broadly and globally. Awareness and the appropriate use of anticoagulant therapy remain the keys to prevention and treatment. However, to assure maximal efficacy and safety, the clinician must, according to the available evidence, choose the right drug, at the right dose, for the right patient, under the right indication, and for the right duration of time. The first International Symposium of Thrombosis and Anticoagulation in Internal Medicine was a scientific program developed by clinicians for clinicians. The primary objective of the meeting was to educate, motivate and inspire internists, cardiologists and hematologists by convening national and international visionaries, thought-leaders and dedicated clinician-scientists in Sao Paulo, Brazil. This article is a focused summary of the symposium proceedings. © Springer Science+Business Media, LLC 2009.en
dc.format.extent106-116-
dc.language.isoeng-
dc.sourceScopus-
dc.subjectAnticoagulation-
dc.subjectInternal medicine-
dc.subjectThrombosis-
dc.subjectacetylsalicylic acid-
dc.subjectanticoagulant agent-
dc.subjectantithrombin-
dc.subjectantithrombocytic agent-
dc.subjectantivitamin K-
dc.subjectapixaban-
dc.subjectazd 0837-
dc.subjectbetrixaban-
dc.subjectblood clotting factor 10a inhibitor-
dc.subjectclopidogrel-
dc.subjectdabigatran-
dc.subjectdalteparin-
dc.subjectdu 176b-
dc.subjectenoxaparin-
dc.subjectfibrinogen receptor antagonist-
dc.subjectfondaparinux-
dc.subjectheparin-
dc.subjecthirulog-
dc.subjectlow molecular weight heparin-
dc.subjectnadroparin-
dc.subjectplacebo-
dc.subjectprasugrel-
dc.subjectpurinergic receptor blocking agent-
dc.subjectreviparin-
dc.subjectrivaroxaban-
dc.subjectstreptokinase-
dc.subjectthrombin inhibitor-
dc.subjecttm 150-
dc.subjectunclassified drug-
dc.subjectunindexed drug-
dc.subjectwarfarin-
dc.subjectym 150-
dc.subjectacute coronary syndrome-
dc.subjectangina pectoris-
dc.subjectanticoagulant therapy-
dc.subjectanticoagulation-
dc.subjectatherogenesis-
dc.subjectbleeding-
dc.subjectBrazil-
dc.subjectcerebrovascular accident-
dc.subjectclinical education-
dc.subjectclinical trial-
dc.subjectdeep vein thrombosis-
dc.subjectdrug mechanism-
dc.subjectdrug metabolism-
dc.subjectembolism-
dc.subjectendothelial dysfunction-
dc.subjectfibrin clot-
dc.subjectheart atrium fibrillation-
dc.subjectheart infarction-
dc.subjecthemostasis-
dc.subjectheparin induced thrombocytopenia-
dc.subjecthuman-
dc.subjectinternal medicine-
dc.subjectinternational normalized ratio-
dc.subjectlow drug dose-
dc.subjectmalignant neoplastic disease-
dc.subjectmedical society-
dc.subjectorthopedic surgery-
dc.subjectoxidative stress-
dc.subjectpharmacogenomics-
dc.subjectpractice guideline-
dc.subjectpriority journal-
dc.subjectprosthetic valve thrombosis-
dc.subjectrecommended drug dose-
dc.subjectrisk assessment-
dc.subjectrisk benefit analysis-
dc.subjectrisk reduction-
dc.subjectST segment elevation-
dc.subjectsurgical risk-
dc.subjectsymposium-
dc.subjectthrombocyte function-
dc.subjectthrombocytopenia-
dc.subjectthromboembolism-
dc.subjectthrombosis-
dc.subjectthrombosis prevention-
dc.subjectvalvular heart disease-
dc.subjectvascular endothelium-
dc.subjectvenous thromboembolism-
dc.subjectAnticoagulants-
dc.subjectCongresses as Topic-
dc.titleHighlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, Brazilen
dc.typeoutro-
dc.contributor.institutionDuke University-
dc.contributor.institutionUniversity of New Mexico-
dc.contributor.institutionBoston University-
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionDante Pazzanese Institute of Cardiology-
dc.contributor.institutionUniversidade Federal da Bahia (UFBA)-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.description.affiliationDuke University School of Medicine, Durham, NC-
dc.description.affiliationUniversity of New Mexico Health Sciences Center, Albuquerque, NM-
dc.description.affiliationBoston University Medical Center, Boston, MA-
dc.description.affiliationFederal University of Sao Paulo, Sao Paulo, SP-
dc.description.affiliationBotucatu School of Medicine, Botucatu, SP-
dc.description.affiliationUniversity of Sao Paulo, Sao Paulo, SP-
dc.description.affiliationDante Pazzanese Institute of Cardiology, Sao Paulo-
dc.description.affiliationFederal University of Bahia, Salvador, BA-
dc.identifier.doi10.1007/s11239-009-0324-4-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofJournal of Thrombosis and Thrombolysis-
dc.identifier.scopus2-s2.0-67549087939-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.